Synthesis of 2-arylated thiadiazolopyrimidones by Suzuki–Miyaura cross-coupling: a new class of nucleotide pyrophosphatase (NPPs) inhibitors
作者:Behzad Jafari、Nazym Yelibayeva、Meirambek Ospanov、Syeda Abida Ejaz、Saira Afzal、Shafi Ullah Khan、Zharylkasyn A. Abilov、Mirgul Z. Turmukhanova、Sergey N. Kalugin、Sayfidin Safarov、Joanna Lecka、Jean Sévigny、Qamar Rahman、Peter Ehlers、Jamshed Iqbal、Peter Langer
DOI:10.1039/c6ra22750c
日期:——
The potential of NPPs inhibitors as therapeutic agents, and the scarceness of their structure–activity relationship, encouraged us to develop new NPP inhibitors. Specifically, 2-bromo-7-methyl-5-oxo-5H-1,3,4-thiadiazolopyrimidine and its corresponding 6-fluoro derivatives were synthesized via a Suzuki–Miyaura reaction. The cross-coupling reaction with different arylboronic acids gave desired coupling
核苷酸焦磷酸酶(NPPs)的过度表达与软骨钙化病,骨关节炎,2型糖尿病,神经退行性疾病,过敏和癌症转移有关。NPPs抑制剂作为治疗剂的潜力以及其结构-活性关系的稀缺性促使我们开发新的NPP抑制剂。具体而言,通过Suzuki-Miyaura反应合成了2-溴7-甲基-5-氧代-5 H -1,3,4-噻二唑并嘧啶及其相应的6-氟衍生物。与不同的芳基硼酸的交叉偶联反应以良好至优异的产率提供了所需的偶联产物,并显示出宽的官能团耐受性。此外,还对所有化合物抑制两个家族的外切核苷酸酶的潜力进行了研究,即核苷三磷酸二磷酸水解酶(NTPDase)和NPP。有趣的是,我们的化合物被确定为NPP的选择性抑制剂。在衍生物5a-5i中,化合物5i(IC 50 ±SEM = 0.39±0.01μM)被发现是h-NPP1的最强抑制剂,而化合物5h(IC 50 ±SEM = 1.02±0.05μM)被认为是h-NPP1的